Related Experiment Videos
The polymorphism of cimetidine.
Journal of Pharmaceutical and Biomedical Analysis
|January 1, 1985
Summary
This study clarifies cimetidine modification nomenclature using high-resolution FT-IR spectroscopy. It rationalizes spectroscopic data for known and novel cimetidine forms, including anhydrous and monohydrate variations.
Area of Science:
- Analytical Chemistry
- Solid-State Chemistry
- Pharmaceutical Science
Background:
- Cimetidine exhibits multiple solid-state modifications, leading to nomenclature ambiguity.
- Understanding these polymorphic forms is crucial for pharmaceutical formulation and stability.
Purpose of the Study:
- To resolve nomenclature uncertainties for cimetidine modifications.
- To characterize unknown cimetidine forms using spectroscopic data.
- To rationalize the FT-IR spectral features of different cimetidine polymorphs.
Main Methods:
- High-resolution Fourier Transform Infrared (FT-IR) spectroscopy was employed.
- Analysis was conducted on five known and two uncharacterized cimetidine modifications.
- Chronological publication order and standard nomenclature conventions were used for identification.
Main Results:
- Spectroscopic data were assigned to specific cimetidine modifications.
- Two previously uncharacterized forms of cimetidine were identified and characterized.
- Distinct spectral differences were observed between anhydrous and monohydrate forms.
- Changes during dehydration of monohydrates without melting were analyzed.
Conclusions:
- The study provides a clear spectroscopic basis for identifying and naming cimetidine modifications.
- FT-IR spectroscopy is a powerful tool for differentiating cimetidine polymorphs.
- The findings contribute to a better understanding of cimetidine's solid-state behavior.